Hot Stocks
Tuesday, June 7, 2016
UPDATE 2-Sarepta says FDA asks for more data for its muscle-wasting treatment
June 6 (Reuters) - Sarepta Therapeutics Inc said
the U.S. Food and Drug Administration has requested for
additional data from an ongoing study for its muscle-wasting
treatment as the agency decides...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment